Latest MS news, study updates, product approvals, and more.

By Lisa Emrich - July 20, 2015
A second case of progressive multifocal leukoencephalopathy (PML) has been reported in an MS patient taking Tecfidera (delayed-release dimethyl fumarate), an oral disease-modifying therapy approved to treat relapsing forms of multiple sclerosis.... READ MORE

By Editorial Team - April 17, 2015
On April 16, Novartis announced the Food & Drug Administration (FDA) approval of Glatopa, the first generic alternate for Teva’s widely used multiple sclerosis therapy, Copaxone. The once per day therapy was developed in collaboration between... READ MORE

SubscribeJoin 43,000 subscribers to our weekly newsletter.

Your username will be visible to others.

Reader favorites